HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical trials in CNS--SMi's eighth annual conference.

Abstract
The SMi's Eighth Annual Conference on Clinical Trials in CNS, held in London, included topics covering new therapeutic developments in the field of CNS disorders. This conference report highlights selected presentations on emerging clinical targets for the treatment of Alzheimer's disease, achievements of the Alzheimer's Disease Neuroimaging Initiative, computational assessment methods applicable to Alzheimer's disease and to the monitoring of suicidality, the accelerated antidepressive effect of PNB-01 (PharmaNeuroBoost NV; comprising a combination of pipamperone and citalopram), and clinical trials in amyotrophic lateral sclerosis and spinal muscular atrophy. Investigational drugs discussed also include begacestat (Pfizer Inc) and olesoxime (Trophos SA).
AuthorsRebecca Kirk
JournalIDrugs : the investigational drugs journal (IDrugs) Vol. 13 Issue 2 Pg. 66-9 (Feb 2010) ISSN: 2040-3410 [Electronic] England
PMID20127552 (Publication Type: Journal Article)
Chemical References
  • Central Nervous System Agents
  • Drugs, Investigational
Topics
  • Animals
  • Central Nervous System Agents (pharmacology)
  • Central Nervous System Diseases (drug therapy, physiopathology)
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • Drug Design
  • Drugs, Investigational (pharmacology)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: